|1.||González-Hernández, M: 4 articles (04/2011 - 06/2002)|
|2.||Gonzalez-Hernandez, M: 3 articles (04/2010 - 01/2007)|
|3.||Caplan, Liron: 2 articles (03/2015 - 06/2013)|
|4.||Sampaolesi, Roberto: 2 articles (03/2013 - 01/2010)|
|5.||Parisi, Lucia: 2 articles (03/2013 - 01/2010)|
|6.||Johnson, Chris A: 2 articles (03/2013 - 01/2010)|
|7.||Zeppieri, Marco: 2 articles (03/2013 - 01/2010)|
|8.||Salvetat, Maria Letizia: 2 articles (03/2013 - 01/2010)|
|9.||Brusini, Paolo: 2 articles (03/2013 - 01/2010)|
|10.||Gonzalez de la Rosa, M: 2 articles (04/2010 - 07/2007)|
02/01/2013 - "This study showed a higher sensitivity and specificity of Pulsar perimetry in comparison to achromatic perimetry in glaucoma patients."
04/01/2011 - "Firstly, the frequency distributions of glaucoma defects on standard automated perimetry (SAP) and the relationship of the centre and periphery (Study A) were studied first, followed by an attempt to establish the limits of pulsar perimetry (Study B). "
09/01/2011 - "Pulsar perimetry in the diagnosis of early glaucoma."
04/01/2011 - "Pulsar allows detecting defects, without range limitations, in the initial half of SAP frequencies expected on glaucoma patients. "
01/01/2010 - "Pulsar perimetry in the diagnosis of early glaucoma."
|2.||Ocular Hypertension (Glaucoma, Suspect)
06/01/2002 - "Pulsar perimetry may have greater sensibility for the detection of early defects in patients with ocular hypertension than conventional perimetry."
06/01/2002 - "To evaluate our first results with Pulsar perimetry in patients with ocular hypertension and compare them with normal individuals. "
06/01/2002 - "[Initial findings with pulsar perimetry in patients with ocular hypertension]."
11/01/2004 - "The novel Pulsar T30W perimetry may be helpful for the study of mild glaucoma and ocular hypertension."
01/01/2007 - "A total of 104 stable eyes (65 subjects) with ocular hypertension and early glaucoma [group G, mean defect = 1.08 dB, SD = 2.0, in standard TOP automatic perimetry (SAP)] were examined 5 times during 18 months using: (a) SAP; (b) Pulsar temporal modulation perimetry (T30W), and (c) frequency-doubling technology (FDT N30). "
|3.||Marek Disease (Marek's Disease)
01/01/2015 - "However, infection of T-cells was greatly enhanced by increasing virus attachment with DEAE dextran and spinoculation, which enhanced the three Env+ virus groups to similar extents. "
07/01/1992 - "It does not require treatment of tissue cells with DEAE-dextran before infection, and it may eliminate the need for serial subpassages of specimens to increase culture sensitivity. "
04/01/1992 - "Optimal infection required the presence of 10 micrograms of DEAE-dextran per ml. The assay was dose dependent with respect to virus input. "
05/01/1986 - "DEAE-dextran had no apparent effects on the dissemination of WEE after infection of either mosquito species. "
05/01/1986 - "Diethylaminoethyl (DEAE)-dextran (1.6 mg/ml), when added to a pledget bloodmeal that contained high concentrations of WEE virus, enhanced peroral infection rates of Cx. "
01/01/1969 - "Effect of DEAE-dextran in vivo on the transplantable ascites tumour JBI in C3H/A mice. "
01/11/1985 - "A factor which eliminated nonspecific transcription of cloned rat rDNA was extensively purified from rat mammary adenocarcinoma ascites cells by successive fractionations on DEAE-Sephadex and heparin-Sepharose columns. "
12/01/1974 - "A substance capable of promoting tumour cell aggregation was released from rat ascites hepatoma cell (possibly from the cell surface) kept in Hanks' balanced salt solution (free of calcium and magnesium) in the cold, and then partially purified by chromatography with DEAE-Sephadex and gel filtration with Bio-gel. "
05/01/1977 - "A glycoprotein antigen from the ascites fluid of pancreatic carcinoma has been isolated with the use of perchloric acid extraction and chromatographies on Sepharose 4B, DEAE-Sephadex, and DE52, followed by Sephadex G-200. "
|1.||Ribosomal DNA (rDNA)